AC Immune Archives

Home AC Immune

Latest Posts

In Depth 11 Apr 2023

Is a vaccine for Parkinson’s disease possible?

Finding a truly effective treatment for Parkinson’s disease - that goes beyond simply managing symptoms - has long been a challenging task and, to this day, there are no available…

April 11, 2023 - 9 minutesmins - By Willow Shah-Neville

News and Trends 3 May 2023

Positive study results: Lilly’s Alzheimer’s drug slows patients’ decline

Eli Lilly and Company has announced positive results of the TRAILBLAZER-ALZ 2 phase 3 study showing that donanemab significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer's…

May 3, 2023 - 8 minutesmins - By Jim Cornall

Best in Biotech 8 Mar 2018

Say Hello to the Top 14 Entrepreneurial Women in European Biotech

Today, March 8, is international women's day. To celebrate the achievements of women we're revisiting our list of the women that have founded some of the hottest biotechs in Europe.…

March 8, 2018 - 8 minutesmins - By Alex Dale

Best in Biotech 21 May 2019

The Top 20 Women in Leading Biotech Roles in Europe

The biotech industry has often been criticized for its lack of gender diversity. While there is still a long way to go to achieve ideal levels of equality, there are…

May 21, 2019 - 12 minutesmins - By Jonathan Smith

News and Trends 8 Mar 2023

The challenges of tackling dementia in women

Dr Andrea Pfeifer, chief executive officer of AC Immune SA, talks to Labiotech about dementia research, and how dementia affects women. She also addresses how vital research is when it…

March 8, 2023 - 5 minutesmins - By Jim Cornall

Best in Biotech 28 Dec 2020

A Year to Remember: The Biggest European Biotech News in 2020

The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled through. Let’s look back at some of the top moments in the last 12 months. …

December 28, 2020 - 12 minutesmins - By Jonathan Smith

News and Trends 2 Sep 2021

AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research

An Alzheimer’s disease drug developed by AC Immune and Genentech has drawn conflicting phase II results this week, raising tentative hopes for the field of treatments targeting the protein tau.…

September 2, 2021 - 5 minutesmins - By Jonathan Smith

More News! 23 Sep 2019

AC Immune Gets €28M from Eli Lilly as Alzheimer’s Drug Hits Phase I

AC Immune will receive €27.6M (CHF 30M) from big pharma Eli Lilly as it begins a phase I trial of its first-in-class Alzheimer’s disease drug. This is the first milestone…

September 23, 2019 - 2 minutesmins - By Jonathan Smith

Best in Biotech 8 May 2019

Top 10 Biotechs in Lausanne

The Swiss city of Lausanne is perhaps best known as a hub of international sport, but what many outsiders may not realize is that it’s also one of Switzerland’s biggest…

May 8, 2019 - 7 minutesmins - By David Cox

Best in Biotech 9 Jan 2018

Happy 2018, Here Are the Top 9 European Biotech Companies To Watch

As the 2017 reports roll in, we're already turning our gaze to 2018. These are the top European biotech companies to watch in the new year. The results from last…

January 9, 2018 - 5 minutesmins - By Evelyn Warner

alzheimers disease acimmune andrea pfeifer 1

Interview 8 Jan 2018

Meet the Swiss CEO Pulling Out All the Stops Against Alzheimer’s Disease

Efforts to treat Alzheimer’s Disease have been hit with failure after failure in the last year or so. Andrea Pfeifer, co-founder and CEO of AC Immune, told me about how…

January 8, 2018 - 8 minutesmins - By Evelyn Warner

alzheimers disease phase iii UK 1 e1557338331863

News and Trends 24 Mar 2020

Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M

A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s disease drug has increased in worth by €38M with a new milestone payment. AC Immune…

March 24, 2020 - 3 minutesmins - By Jonathan Smith

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

Download Inpart’s latest report

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inpart, the leading platform for biopharma partnering